Amanda N Buxton
Overview
Explore the profile of Amanda N Buxton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Susin C, Lee J, Fiorini T, de Freitas R, Chiu H, Prasad H, et al.
J Clin Periodontol
. 2018 May;
45(8):1005-1013.
PMID: 29757470
Background: Recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge carrier (rhBMP-2/ACS) has been shown to support significant bone formation when used to augment the maxillary sinus for implant...
2.
Susin C, Fiorini T, Lee J, de Freitas R, Chiu H, Prasad H, et al.
J Clin Periodontol
. 2017 Jun;
44(10):1059-1066.
PMID: 28644556
Background: Present clinical practice broadly relies on off-the-shelf allogeneic, xenogeneic or synthetic bone biomaterials in support of sinus augmentation. Also, recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge...
3.
Pelaez M, Susin C, Lee J, Fiorini T, Bisch F, Dixon D, et al.
J Clin Periodontol
. 2014 May;
41(8):827-36.
PMID: 24807100
Background: Application of recombinant human bone morphogenetic protein-2 (rhBMP-2) has been associated with significant adverse events in craniofacial settings, including swelling and seroma formation. Recent work has demonstrated an inverse...
4.
Lu S, Fiorini T, Lee J, Prasad H, Buxton A, Bisch F, et al.
J Clin Periodontol
. 2013 May;
40(7):688-97.
PMID: 23627347
Background: Previous studies document the therapeutic potential of recombinant human bone morphogenetic protein-2 (rhBMP-2) in an absorbable collagen sponge (ACS) carrier for indications in the axial and appendicular skeleton. Nevertheless,...
5.
Lee J, Susin C, Rodriguez N, DE Stefano J, Prasad H, Buxton A, et al.
Clin Oral Implants Res
. 2012 Jan;
24(5):497-504.
PMID: 22276816
Background: Implant dentistry in the posterior maxilla often requires bone augmentation. The gold standard, autogenous bone graft, requires additional surgery with associated morbidity, while bone biomaterials may not support relevant...
6.
Herford A, Lu M, Buxton A, Kim J, Henkin J, Boyne P, et al.
J Oral Maxillofac Surg
. 2011 May;
70(3):703-16.
PMID: 21549480
Purpose: Recombinant human bone morphogenetic protein 2 (rhBMP-2) is an option for reconstructing mandibular continuity defects. A challenge of this technique is the need to maintain sufficient space to avoid...
7.
Buxton A, Bahney C, Yoo J, Johnstone B
Tissue Eng Part A
. 2010 Aug;
17(3-4):371-80.
PMID: 20799905
Tissue engineering utilizes scaffolds containing chondrogenic cells to promote cartilage development at a clinically relevant scale, yet there remains a limited understanding of the optimal conditions for inducing differentiation and...
8.
Buxton A, Zhu J, Marchant R, West J, Yoo J, Johnstone B
Tissue Eng
. 2007 Jul;
13(10):2549-60.
PMID: 17655489
Mesenchymal stem cells (MSCs) are used extensively in cartilage tissue engineering. We have developed a photopolymerizable poly(ethylene glycol diacrylate) (PEGDA) and poly(ethylene glycol) (PEG) semi-interpenetrating network that facilitates the in...